期刊文献+

扶正祛邪法对肺癌患者免疫功能及血清可溶性Fas凋亡抵抗的影响 被引量:3

Effect of Therapy of Supporting Healthy Qi and Dispelling Pathogenic Qi on Immune Function and Serum Soluble Fas Apoptosis Resistance in Lung Cancer Patients
下载PDF
导出
摘要 【目的】观察扶正祛邪法对痰瘀互结证肺癌患者的免疫功能及血清可溶性Fas(sFas)凋亡抵抗的影响。【方法】将76例痰瘀互结证非小细胞肺癌患者随机分为2组。对照组38例采用吉西他滨/顺铂(GP)方案化疗,4周为1个周期,治疗6个周期;治疗组38例则在GP方案化疗的基础上加用肺癌合剂,2个月为1个疗程,共治疗3个疗程。对比观察2组治疗前后肺癌患者免疫功能及血清sFas凋亡抵抗的影响。【结果】治疗后治疗组的CD3、CD4、CD4/CD8比值及自然杀伤(NK)细胞均高于对照组(P<0.05或P<0.01);而血清sFas水平显著低于对照组(P<0.01)。【结论】扶正祛邪法中药制剂不但可以减轻化疗对肺癌患者免疫系统的损伤,提高肺癌患者的免疫功能,还可以抑制肿瘤细胞的凋亡抵抗。 Objective To observe the effect of therapy of supporting healthy Qi and dispelling pathogenic Qi on immune function and serum soluble Fas (sFas) apoptosis resistance in lung cancer patients. Methods Seventy-six non-small-cell lung cancer patients with phlegm blended with blood stasis were equally randomized into the treatment group and the control group. The two groups received the regimen of gemcitabine/platinol (GP) chemotherapy, 4 weeks constituted one treatment course, and the treatment lasted 6 courses. The treatment group received Lung Cancer Mixture on the basis of GP regimen, 2 months constituted one treatment course, and the treatment lasted 3 courses. The changes of immune function and serum sFas apoptosis resistance in two groups were observed before and after treatment. Results After treatment, the percentages of CD3 and CD4, CDJCDs ratio and the number of natural killer (NK) cells were higher (P 〈0. 05 or P 〈0.01 ) , but serum sFas level was lower in the treatment group than those in the control group (P 〈 0.01 ). Conclusion Chinese herbal medicinal prescriptions, which have the actions of supporting healthy Qi and dispelling pathogenic Qi, can improve the immune function and inhibit the tumor cell apoptosis resistance in lung cancer patients.
作者 唐兴荣
出处 《广州中医药大学学报》 CAS 2010年第6期566-568,共3页 Journal of Guangzhou University of Traditional Chinese Medicine
关键词 肺癌/中西医结合疗法 肺癌合剂/治疗应用 T淋巴细胞亚群/血液 NK细胞/血液 细胞凋亡 扶正祛邪 LUNG CANCER/TCM-WM tFerapy LUNG CANCER MIXTURE/therapeutic sue T LYMPHOCYTE SUBTYPES/blood NK CELLS/blood APOPTOSIS SUPPORTING HEALTHY QI AND DISPELLING PATHOGENIC QI
  • 相关文献

参考文献7

二级参考文献61

  • 1沈自尹 王文健.中医虚证辨证参考标准[J].中西医结合杂志,1986,6(10):598-598.
  • 2焦顺昌,路军章.表格式临床医学系列丛书:肿瘤分册[M].北京:中国医药科技出版社,2002:495-496.
  • 3Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors[J]. J Natl Cancer Inst, 2000, 92(3): 205-216.
  • 4国家技术监督局.GB/T16751.2-1997中医临床诊疗术语证候部分[S].北京:中国标准出版社,1997:1-11.
  • 5中华人民共和国卫生部医政司编.中国常见恶性肿瘤诊治规范.第六分册.第2版.北京:北京医科大学、中国协和医科大学联合出版社,1991.2-13.
  • 6Mulshine JL,Sullivan DC.Clinical practice.Lung cancer screening.N Engl J Med,2005,352(26):2714-2720.
  • 7James IM.Early detection of lung cancer:where we are going?J Thorac Oncol,2007,2(8 Suppl 4):s296
  • 8Biomarkers and risk models for stratification of high risk individuals.J Thorac Oncol,2007,2(8 Suppl 4):s176
  • 9Hensehke CI,Yankdevitz DF,Libby DM,Pasmantier MW,Smith JP,Miettinen OS.Survival of patients with stage Ⅰ lung cancer detected on CT screening.New Engl J Med 2006,355(17):1763-1771.
  • 10Bach PB,Jett JR,Pastorino U,Tockman MS,Swensen SJ,Begg CB.Computed tomography screening and lung cancer outcomes.JAMA,2007,297(9):953-961.

共引文献876

同被引文献10

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部